TOPPER JAMES N purchased 15.4% of their position (7.42K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $24.5K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/15/2025ACC: 0001415889-25-013134
Director10% Owner
Since Oct 2019
+7.42K
Net shares
Net buyer
$24.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
7.42K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.12K
Price / share
$3.16
Trade value
$3.54K
% of position
2.3%
5/13/2025
48.20K→49.32K
Common Stock
Indirect
Shares
+6.30K
Price / share
$3.32
Trade value
$20.92K
% of position
12.8%
5/14/2025
49.32K→55.62K
Total
Net shares
+7.42K
Net value
$24.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/13/2025 | P · Purchase | +1.12K | $3.16 | $3.54K | 2.3% | 48.20K | 49.32K |
| Common Stock Indirect | 5/14/2025 | P · Purchase | +6.30K | $3.32 | $20.92K | 12.8% | 49.32K | 55.62K |
| Total | +7.42K | $24.46K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned1.00
Common Stock
DirectShares owned32.10K
Common Stock
IndirectShares owned5.83M
Common Stock
IndirectShares owned3.91K
Total
32.10K direct·5.83M indirect5.86M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.00 | Indirect |
| Common Stock | 32.10K | Direct |
| Common Stock | 5.83M | Indirect |
| Common Stock | 3.91K | Indirect |
| Total | 5.86M | 32.10K direct·5.83M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported